Mr. Zohar Krivorot reports

CANNARA TO ANNOUNCE FISCAL Q2 2026 FINANCIAL RESULTS ON APRIL 14, 2026

Cannara Biotech Inc. will release its financial results for the fiscal second quarter ended Feb. 28, 2026, on Tuesday, April 14, 2026, at 7 a.m. ET.

Cannara Biotech chief executive officer Zohar Krivorot and chief financial officer Nicholas Sosiak will host an earnings webcast on Tuesday, April 14, 2026, at 10 a.m. ET, consisting of prepared remarks followed by a question-and-answer session.

Investors are encouraged to submit questions by e-mail in advance to investors@cannara.ca. For interested individuals unable to join, the event will be archived on the company's website.

Haywood Securities coverage initiation

The company is also pleased to announce that Haywood Securities has initiated coverage on Cannara as of April 6, 2026. Haywood Securities' research report on Cannara is available through their platform. Please note that any opinions or forecasts regarding the company made by Haywood Securities are theirs alone and neither represent the opinions or forecasts of Cannara or its management, nor imply that the company endorses or approves such information, conclusions or recommendations.

About Cannara Biotech Inc.

Cannara Biotech is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Quebec spanning over 1.6 million square feet, providing the company with 100,000 kilograms of potential annualized cultivation output. Leveraging Quebec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price.